Visit Us @
Synergy Centre TU Dublin, Tallaght, D24A386
Mail Us @
info@codlad.com
Call Us @
+353 851890752

Archive for July, 2023

FDA Roundup: July 7, 2023

July 7, 2023

FDA Roundup: July 7, 2023

Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the U.S. Embassy & Consulates in…

FDA Roundup: July 7, 2023 FDA
FDA Converts Novel Alzheimer’s Disease Treatment to Traditional Approval

July 6, 2023

FDA Converts Novel Alzheimer’s Disease Treatment to Traditional Approval

Today, the U.S. Food and Drug Administration converted Leqembi (lecanemab-irmb), indicated to treat adult patients with Alzheimer’s Disease, to traditional approval following a determination that…

FDA Converts Novel Alzheimer’s Disease Treatment to Traditional Approval FDA
FDA, FTC Warn Six Companies for Illegally Selling Copycat Food Products Containing Delta-8 THC

July 5, 2023

FDA, FTC Warn Six Companies for Illegally Selling Copycat Food Products Containing Delta-8 THC

Today, the U.S. Food and Drug Administration and the Federal Trade Commission issued warning letters to six companies for illegally selling copycat food products containing…

FDA, FTC Warn Six Companies for Illegally Selling Copycat Food Products Containing Delta-8 THC FDA
  • 1
  • 2

Latest Posts

FDA Approves Drug to Treat Neurologic Manifestations of Hunter Syndrome
FDA Approves Drug to Treat Neurologic Manifestations of Hunter Syndrome
March 25, 2026
FDA Schedules Public Meeting on the Commissioner’s National Priority Voucher Pilot Program
FDA Schedules Public Meeting on the Commissioner’s National Priority Voucher Pilot Program
March 20, 2026
FDA Approves Fourth Product Under National Priority Voucher Program, Higher Dose Semaglutide
FDA Approves Fourth Product Under National Priority Voucher Program, Higher Dose Semaglutide
March 19, 2026